{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:19:42Z","timestamp":1790234382585,"version":"4.1.0"},"reference-count":121,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001960","name":"American Society for Radiation Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001960","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001960","name":"American Society for Radiation Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001960","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ijrobp.2019.07.026","type":"journal-article","created":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T19:42:52Z","timestamp":1564774972000},"page":"698-712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"title":["The Implications of Genetic Testing on Radiation Therapy Decisions: A Guide for Radiation Oncologists"],"prefix":"10.1016","volume":"105","author":[{"given":"Carmen","family":"Bergom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharine M.","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Higginson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed E.","family":"Abazeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banu","family":"Arun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soren M.","family":"Bentzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonine L.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaden D.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naamit K.","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L.","family":"Kerns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Keen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer K.","family":"Litton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne S.","family":"Reiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem","family":"Riaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry S.","family":"Rosenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel O.","family":"Sawakuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona F.","family":"Shaitelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon N.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy A.","family":"Woodward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2019.07.026_bib1","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1200\/JCO.2015.63.0996","article-title":"American Society of Clinical Oncology policy statement update: Genetic and genomic testing for cancer susceptibility","volume":"33","author":"Robson","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/gim.2014.147","article-title":"A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: Referral indications for cancer predisposition assessment","volume":"17","author":"Hampel","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology","volume":"17","author":"Cheng","year":"2015","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib4","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","article-title":"Gene-panel sequencing and the prediction of breast-cancer risk","volume":"372","author":"Easton","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib5","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/gim.2015.166","article-title":"Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing","volume":"18","author":"Susswein","year":"2016","journal-title":"Genet Med"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cncr.29010","article-title":"Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel","volume":"121","author":"Tung","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib7","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cancergen.2015.12.013","article-title":"Increased yield of actionable mutations using multi-gene panels to assess hereditary cancer susceptibility in an ethnically diverse clinical cohort","volume":"209","author":"Ricker","year":"2016","journal-title":"Cancer Genet"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1200\/JCO.18.01631","article-title":"Underdiagnosis of hereditary breast cancer: Are genetic testing guidelines a tool or an obstacle?","volume":"37","author":"Beitsch","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib9","first-page":"1502","article-title":"Outcomes after adjuvant radiotherapy in breast cancer patients with and without germline mutations: A large, single-institutional experience","volume":"37","author":"Chapman","year":"2019","journal-title":"ASCO Annu Meet Abstr"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib10","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/jamaoncol.2017.0424","article-title":"Associations between cancer predisposition testing panel genes and breast cancer","volume":"3","author":"Couch","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib11","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/s41467-017-00921-w","article-title":"Pan-cancer analysis of bi-allelic alterations in homologous recombination DNA repair genes","volume":"8","author":"Riaz","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib12","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium","volume":"62","author":"Ford","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib13","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib14","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1002\/cam4.1519","article-title":"Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer","volume":"7","author":"Elsayegh","year":"2018","journal-title":"Cancer Med"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib15","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa1706450","article-title":"Olaparib for metastatic breast cancer in patients with a germline BRCA mutation","volume":"377","author":"Robson","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib16","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJMoa1802905","article-title":"Talazoparib in patients with advanced breast cancer and a germline BRCA mutation","volume":"379","author":"Litton","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib17","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1200\/JCO.2000.18.19.3360","article-title":"Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1\/2 mutations","volume":"18","author":"Pierce","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib18","doi-asserted-by":"crossref","first-page":"7025","DOI":"10.1158\/1078-0432.CCR-06-1244","article-title":"Late toxicity is not increased in BRCA1\/BRCA2 mutation carriers undergoing breast radiotherapy in the United Kingdom","volume":"12","author":"Shanley","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.semradonc.2010.08.008","article-title":"Radiotherapy in the treatment of hereditary breast cancer","volume":"21","author":"Pierce","year":"2011","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib20","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000354834","article-title":"The influence of BRCA1\/BRCA2 mutations on toxicity related to chemotherapy and\u00a0radiotherapy in early breast cancer patients","volume":"85","author":"Huszno","year":"2013","journal-title":"Oncology"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib21","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jama.2017.11137","article-title":"Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing","volume":"318","author":"Mandelker","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cell.2018.03.039","article-title":"Pathogenic germline variants in 10,389 adult cancers","volume":"173","author":"Huang","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1667\/RR0763.1","article-title":"Solid cancer incidence in atomic bomb survivors: 1958-1998","volume":"168","author":"Preston","year":"2007","journal-title":"Radiat. Res"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib24","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/HP.0b013e3181b08a10","article-title":"Radiation carcinogenesis in context: How do irradiated tissues become tumors?","volume":"97","author":"Barcellos-Hoff","year":"2009","journal-title":"Health Phys"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib25","doi-asserted-by":"crossref","first-page":"12605","DOI":"10.1038\/ncomms12605","article-title":"Mutational signatures of ionizing radiation in second malignancies","volume":"7","author":"Behjati","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib26","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1470-2045(11)70061-4","article-title":"Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries","volume":"12","author":"Berrington de Gonzalez","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib27","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jama.2017.0693","article-title":"Temporal trends in treatment and subsequent neoplasm risk among 5-year survivors of childhood cancer, 1970-2015","volume":"317","author":"Turcotte","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib28","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.dnarep.2004.04.009","article-title":"Ataxia-telangiectasia-like disorder (ATLD)-its clinical presentation and molecular basis","volume":"3","author":"Taylor","year":"2004","journal-title":"DNA Repair Amst"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib29","doi-asserted-by":"crossref","first-page":"16910","DOI":"10.1073\/pnas.0708408104","article-title":"RIDDLE immunodeficiency syndrome is linked to defects in 53BP1-mediated DNA damage signaling","volume":"104","author":"Stewart","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib30","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1093\/hmg\/ddh221","article-title":"MRE11 mutations and impaired ATM-dependent responses in an Italian family with ataxia-telangiectasia-like disorder","volume":"13","author":"Delia","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib31","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/hmg\/ddn369","article-title":"Cornelia de Lange syndrome mutations in SMC1A or SMC3 affect binding to DNA","volume":"18","author":"Revenkova","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0167-8140(00)00249-8","article-title":"Four radiation hypersensitivity cases and their implications for clinical radiotherapy","volume":"57","author":"Rogers","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib33","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.ijrobp.2009.02.057","article-title":"Clinical Radiation Sensitivity with DNA Repair Disorders: An Overview","volume":"74","author":"Pollard","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib34","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ajhg.2009.04.010","article-title":"Human RAD50 deficiency in a Nijmegen breakage syndrome-like disorder","volume":"84","author":"Waltes","year":"2009","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib35","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jmoldx.2015.05.004","article-title":"Evaluation of severe combined immunodeficiency and combined immunodeficiency pediatric patients on the basis of cellular radiosensitivity","volume":"17","author":"Lobachevsky","year":"2015","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0167-8140(01)00370-X","article-title":"Normal cellular radiosensitivity in an adult Fanconi anaemia patient with marked clinical radiosensitivity","volume":"60","author":"Marcou","year":"2001","journal-title":"Radiother Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.ijrobp.2019.07.026_bib37","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1007\/s00247-008-1015-6","article-title":"Radiation-sensitive genetically susceptible pediatric sub-populations","volume":"39","author":"Kleinerman","year":"2009","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib38","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1667\/RR1943.1","article-title":"G2-phase chromosomal radiosensitivity of primary fibroblasts from hereditary retinoblastoma family members and some apparently normal controls","volume":"173","author":"Wilson","year":"2010","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib39","doi-asserted-by":"crossref","first-page":"E620","DOI":"10.1016\/j.ijrobp.2017.06.2096","article-title":"Severe radiation toxicity associated with a germline PTEN mutation","volume":"99","author":"Tatebe","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib40","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ijrobp.2018.05.057","article-title":"Severe PATCHED1 deficiency in cancer-prone gorlin patient cells results in intrinsic radiosensitivity","volume":"102","author":"Vulin","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib41","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/oxfordjournals.aje.a010202","article-title":"An iatrogenic epidemic of benign meningioma","volume":"151","author":"Sadetzki","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib42","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1470-2045(07)70107-9","article-title":"Genetic predisposition for the development of radiation-associated meningioma: an epidemiological study","volume":"8","author":"Flint-Richter","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib43","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0161-6420(88)32971-4","article-title":"Incidence of second neoplasms in patients with bilateral retinoblastoma","volume":"95","author":"Roarty","year":"1988","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib44","first-page":"1573","article-title":"International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis 1","volume":"62","author":"Ferner","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib45","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/neuonc\/nos287","article-title":"Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1","volume":"15","author":"Kolberg","year":"2013","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib46","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/jamadermatol.2016.4347","article-title":"Risk factors for basal cell carcinoma among patients with basal cell nevus syndrome: Development of a basal cell nevus syndrome patient registry","volume":"153","author":"Solis","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib47","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.ijrobp.2013.06.186","article-title":"Subsequent malignancies in patients with Li-Fraumeni syndrome treated with radiation therapy","volume":"87","author":"Suri","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib48","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1748-717X-5-104","article-title":"Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome","volume":"5","author":"Heymann","year":"2010","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib49","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1002\/cncr.30248","article-title":"Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort","volume":"122","author":"Mai","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib50","first-page":"531210","article-title":"Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes","author":"Karczewski","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib51","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/ijc.10367","article-title":"Variation in breast cancer risk of heterozygotes for ataxia-telangiectasia according to environmental factors","volume":"99","author":"Geoffroy-Perez","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib52","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/ng1837","article-title":"ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles","volume":"38","author":"Renwick","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib53","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/jnci\/dji141","article-title":"Cancer risks and mortality in heterozygous ATM mutation carriers","volume":"97","author":"Thompson","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib54","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1080\/09553002.2017.1344363","article-title":"ATM, radiation, and the risk of second primary breast cancer","volume":"93","author":"Bernstein","year":"2017","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib55","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jnci\/djq055","article-title":"Radiation exposure, the ATM Gene, and contralateral breast cancer in the women\u2019s environmental cancer and radiation epidemiology study","volume":"102","author":"Bernstein","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib56","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1056\/NEJM199112263252602","article-title":"Incidence of cancer in 161 families affected by ataxia\u2013telangiectasia","volume":"325","author":"Swift","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib57","doi-asserted-by":"crossref","first-page":"6486","DOI":"10.1158\/0008-5472.CAN-08-0134","article-title":"Variants in the ATM gene associated with a reduced risk of contralateral breast cancer","volume":"68","author":"Concannon","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib58","unstructured":"National Cancer Institute. SEER*Stat database: Incidence, SEER 9\u00a0regs limited use, Nov 206 sub (1973-2004), linked to county attributes, total U.S. 1969-2004 counties. https:\/\/seer.cancer.gov\/data-software\/documentation\/seerstat\/nov2016\/. Accessed February 14,2008."},{"key":"10.1016\/j.ijrobp.2019.07.026_bib59","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1016\/j.ejca.2013.04.028","article-title":"Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: A WECARE study report","volume":"49","author":"Bernstein","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib60","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/annonc\/mdy515","article-title":"Prophylactic irradiation to the contralateral breast for BRCA mutation carriers with early stage breast cancer","volume":"30","author":"Evron","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib61","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S1097-2765(01)00408-7","article-title":"DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency","volume":"8","author":"O\u2019Driscoll","year":"2001","journal-title":"Mol Cell"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib62","doi-asserted-by":"crossref","first-page":"e484","DOI":"10.1542\/peds.2012-3815","article-title":"Immunologic features of Cornelia de Lange syndrome","volume":"132","author":"Jyonouchi","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib63","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/humu.21315","article-title":"Clinical variability and\u00a0novel mutations in the NHEJ1 gene in patients with a Nijmegen breakage syndrome-like phenotype","volume":"31","author":"Dutrannoy","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib64","first-page":"7","article-title":"Neurological manifestations of primary immunodeficiencies","volume":"12","author":"Chavoshzadeh","year":"2018","journal-title":"Iran J Child Neurol"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib65","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/hed.25577","article-title":"Treatment modalities and outcomes of Fanconi anemia patients with head and neck squamous cell carcinoma: Series of 9 cases and review of the literature","volume":"41","author":"Beckham","year":"2019","journal-title":"Head Neck"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib66","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2307\/3578071","article-title":"Assessment of chronic gamma radiosensitivity as an in\u00a0vitro assay for heterozygote identification of ataxia-telangiectasia","volume":"128","author":"Weeks","year":"1991","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib67","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.asr.2005.01.030","article-title":"Mice heterozygous for the ATM gene are more sensitive to both X-ray and heavy ion exposure than are wildtypes","volume":"35","author":"Worgul","year":"2005","journal-title":"Adv Space Res"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib68","doi-asserted-by":"crossref","first-page":"9836","DOI":"10.1073\/pnas.162349699","article-title":"Atm heterozygous mice are more sensitive to radiation-induced cataracts than are their wild-type counterparts","volume":"99","author":"Worgul","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib69","first-page":"5710","article-title":"Modest increased sensitivity to radiation oncogenesis in ATM heterozygous versus wild-type mammalian cells","volume":"61","author":"Smilenov","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib70","first-page":"e1458","article-title":"Severe late toxicity after adjuvant breast radiotherapy in a patient with a germline ataxia telangiectasia mutated gene: Future treatment decisions","volume":"9","author":"Dosani","year":"2017","journal-title":"Cureus"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib71","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.radonc.2003.08.004","article-title":"Clinical radiosensitivity in breast cancer patients carrying pathogenic ATM gene mutations: No observation of increased radiation-induced acute or late effects","volume":"69","author":"Bremer","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib72","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0360-3016(98)00295-8","article-title":"Radiosensitivity of normal tissues in ataxia-telangiectasia heterozygotes","volume":"42","author":"Weissberg","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib73","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.ijrobp.2014.12.041","article-title":"Ataxia telangiectasia-mutated gene polymorphisms and acute normal tissue injuries in cancer patients after radiation therapy: A systematic review and meta-analysis","volume":"91","author":"Dong","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib74","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0360-3016(01)02690-6","article-title":"Deterministic rather than stochastic factors explain most of the variation in the expression of skin telangiectasia after radiotherapy","volume":"52","author":"Safwat","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib75","doi-asserted-by":"crossref","first-page":"5993","DOI":"10.1158\/0008-5472.CAN-06-1007","article-title":"Mutagen sensitivity has high heritability: Evidence from a twin study","volume":"66","author":"Wu","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib76","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1470-2045(11)70302-3","article-title":"Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: A prospective analysis study","volume":"13","author":"Barnett","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib77","doi-asserted-by":"crossref","first-page":"e3267","DOI":"10.1097\/MD.0000000000003267","article-title":"Single nucleotide polymorphism rs1801516 in ataxia telangiectasia-mutated gene predicts late fibrosis in cancer patients after radiotherapy: A PRISMA-compliant systematic review and meta-analysis","volume":"95","author":"Zhang","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib78","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.radonc.2016.06.017","article-title":"Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients","volume":"121","author":"Andreassen","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib79","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra0905980","article-title":"Genomewide association studies and assessment of the risk of disease","volume":"363","author":"Manolio","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib80","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1158\/2159-8290.CD-13-0197","article-title":"Radiogenomics: Using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy","volume":"4","author":"Kerns","year":"2014","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib81","doi-asserted-by":"crossref","unstructured":"Kerns SL, Fachal L, Dorling L, et\u00a0al. Radiogenomics consortium genome-wide association study meta-analysis of late toxicity after prostate cancer radiotherapy [e-pub ahead of print]. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djz075. Accessed May 16,\u00a02019.","DOI":"10.1093\/jnci\/djz075"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib82","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.clon.2014.09.008","article-title":"The REQUITE project: Validating predictive models and biomarkers of radiotherapy toxicity to reduce side-effects and improve quality of life in cancer survivors","volume":"26","author":"West","year":"2014","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib83","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0167-8140(19)31067-9","article-title":"Analysis of biomarkers for late radiotherapy toxicity in the REQUITE project","volume":"133","author":"Talbot","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib84","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/ng.3020","article-title":"A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1","volume":"46","author":"Fachal","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib85","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ebiom.2016.07.022","article-title":"Meta-analysis of genome wide association studies identifies genetic markers of late toxicity following radiotherapy for prostate cancer","volume":"10","author":"Kerns","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib86","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1056\/NEJMp1904511","article-title":"Has the genome granted our wish yet?","volume":"380","author":"Hunter","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib87","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/path.4890","article-title":"Bi-allelic alterations in DNA repair genes underpin homologous recombination DNA repair defects in breast cancer","volume":"242","author":"Mutter","year":"2017","journal-title":"J Pathol"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib88","article-title":"Breast conservation and hypofractionation in women with hereditary breast cancer","author":"Ghobrial","year":"2019","journal-title":"ASTRO 61st Annu Meet Abstr"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib89","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/bjc.2016.94","article-title":"Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity","volume":"114","author":"Ahmed","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib90","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1158\/1078-0432.CCR-15-1080","article-title":"Patients with a high polygenic risk of breast cancer do not have an increased risk of radiotherapy toxicity","volume":"22","author":"Dorling","year":"2016","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib91","doi-asserted-by":"crossref","first-page":"11428","DOI":"10.1038\/ncomms11428","article-title":"A genetic basis for the variation in the vulnerability of cancer to DNA damage","volume":"7","author":"Yard","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib92","doi-asserted-by":"crossref","first-page":"10312","DOI":"10.18632\/oncotarget.14400","article-title":"Genomic analysis of exceptional responders to radiotherapy reveals somatic mutations in ATM","volume":"8","author":"Ma","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib93","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/j.ijrobp.2018.06.183","article-title":"Pathogenic mutations in ATM enhance radio-sensitivity and local control in patients with primary and metastatic breast cancer","volume":"102","author":"Casey","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib94","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.1016\/j.ijrobp.2018.07.338","article-title":"Pathogenic mutations in ATM predict for enhanced local control in prostate cancers treated with radiation therapy","volume":"102","author":"Lu","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib95","doi-asserted-by":"crossref","first-page":"S226","DOI":"10.1016\/j.ijrobp.2018.07.155","article-title":"Pathogenic mutations in ATM as determinants of local control in non-small cell lung cancers treated with radiation therapy","volume":"102","author":"Pitter","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib96","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cllc.2014.09.005","article-title":"Outcomes by tumor histology and KRAS mutation status after lung stereotactic body radiation therapy for early-stage non-small-cell lung cancer","volume":"16","author":"Mak","year":"2015","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib97","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1245\/s10434-016-5205-4","article-title":"KRAS and combined KRAS\/TP53 mutations in locally advanced rectal cancer are independently associated with decreased response to neoadjuvant therapy","volume":"23","author":"Chow","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib98","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx031","article-title":"Phase II study of proton-based stereotactic body radiation therapy for liver metastases: Importance of tumor genotype","volume":"109","author":"Hong","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib99","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1158\/0008-5472.CAN-16-0808","article-title":"Radiation resistance in KRAS-mutated lung cancer is enabled by stem-like properties mediated by an osteopontin-EGFR pathway","volume":"77","author":"Wang","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib100","first-page":"0008","article-title":"Global downstream pathway analysis reveals a dependence of oncogenic NF-E2\u2013related factor 2 mutation on the mTOR growth signaling pathway","author":"Shibata","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib101","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1158\/2159-8290.CD-16-0127","article-title":"Role of KEAP1\/NRF2 and TP53 mutations in lung squamous cell carcinoma development and radiation resistance","volume":"7","author":"Jeong","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib102","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature11404","article-title":"Comprehensive genomic characterization of squamous cell lung cancers","volume":"489","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib103","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature13385","article-title":"Comprehensive molecular profiling of lung adenocarcinoma","volume":"511","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib104","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ijrobp.2017.05.044","article-title":"Precision oncology and genomically guided radiation therapy: A report from the American Society for Radiation Oncology\/American Association of Physicists in Medicine\/National Cancer Institute Precision Medicine Conference","volume":"101","author":"Hall","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib105","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S1470-2045(16)30491-0","article-title":"Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis","volume":"17","author":"Zhao","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib106","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S1470-2045(16)30648-9","article-title":"A genome-based model for adjusting radiotherapy dose (GARD): A retrospective, cohort-based study","volume":"18","author":"Scott","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib107","unstructured":"PROMPT. Prospective Registry of MultiPlex Testing. Available at: http:\/\/www.promptstudy.org. Accessed May 19,\u00a02019."},{"key":"10.1016\/j.ijrobp.2019.07.026_bib108","unstructured":"Enigma Consortium. Evidence-based network for the interpretation of germline mutant alleles. Available at: http:\/\/www.enigmaconsortium.org. Accessed May 19,\u00a02019."},{"key":"10.1016\/j.ijrobp.2019.07.026_bib109","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/humu.23637","article-title":"ClinGen Allele Registry links information about genetic variants","volume":"39","author":"Pawliczek","year":"2018","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib110","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1016\/j.ijrobp.2009.08.076","article-title":"Biomarkers and surrogate endpoints for normal-tissue effects of radiation therapy: The importance of dose-volume effects","volume":"76","author":"Bentzen","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib111","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.radonc.2012.11.004","article-title":"Conducting radiogenomic research\u2014do not forget careful consideration of the clinical data","volume":"105","author":"Andreassen","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib112","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ijrobp.2011.03.015","article-title":"Standardized Total Average Toxicity score: A scale- and grade-independent measure of late radiotherapy toxicity to facilitate pooling of data from different studies","volume":"82","author":"Barnett","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib113","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1086\/302544","article-title":"Heritability of cellular radiosensitivity: A marker of low-penetrance predisposition genes in breast cancer?","volume":"65","author":"Roberts","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib114","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1080\/09553000050201109","article-title":"Heritability of chromosomal radiosensitivity in breast cancer patients: A pilot study with the lymphocyte micronucleus assay","volume":"76","author":"Burrill","year":"2000","journal-title":"Int. J. Radiat. Biol"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib115","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/sj.bjc.6602807","article-title":"G(2) chromosomal radiosensitivity in Danish survivors of childhood and adolescent cancer and their offspring","volume":"93","author":"Curwen","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib116","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.radonc.2007.04.010","article-title":"Genetic determination of chromosomal radiosensitivities in G0- and G2-phase human lymphocytes","volume":"83","author":"Borgmann","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib117","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.ijrobp.2007.03.050","article-title":"Heritability of susceptibility to ionizing radiation-induced apoptosis of human lymphocyte subpopulations","volume":"68","author":"Schmitz","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib118","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00439-008-0500-1","article-title":"Evidence for significant heritability of apoptotic and cell cycle responses to ionising radiation","volume":"123","author":"Finnon","year":"2008","journal-title":"Hum Genet"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib119","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3109\/09553002.2010.496027","article-title":"The heritability of G2 chromosomal radiosensitivity and its association with cancer in Danish cancer survivors and their offspring","volume":"86","author":"Curwen","year":"2010","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib120","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/mutage\/geq059","article-title":"Heritability of baseline and induced micronucleus frequencies","volume":"26","author":"Surowy","year":"2011","journal-title":"Mutagenesis"},{"key":"10.1016\/j.ijrobp.2019.07.026_bib121","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10142-019-00658-3","article-title":"Combining CDKN1A gene expression and genome-wide SNPs in a twin cohort to gain insight into the heritability of individual radiosensitivity","volume":"19","author":"Zyla","year":"2019","journal-title":"Funct Integr Genomics"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301619335308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301619335308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:45:44Z","timestamp":1759743944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301619335308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":121,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0360301619335308"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2019.07.026","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Implications of Genetic Testing on Radiation Therapy Decisions: A Guide for Radiation Oncologists","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2019.07.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}